InfuSystem Holdings, Inc. (INFU) Reports $13.1 Million of Revenues and $3.7 Million of Adjusted EBITDA for the Fourth Quarter of 2010
MADISON HEIGHTS, Mich., March 10, 2011 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and related services, today reported results for the fourth quarter and fiscal year ended December 31, 2010.
Fiscal 2010: Continued Growth in Revenues, Adjusted EBITDA and Cash from Operations
“We are pleased with the fourth quarter and fiscal year performance and the reporting of the thirteenth straight quarter of year over year growth for the company. With the continued steady growth of our core business and strategic initiatives to broaden our product and service offering, we are more confident than ever in the long-term outlook for the company and industry as InfuSystem continues to successfully execute its long-term business strategy. We are a healthcare growth company with healthy profits” said Sean McDevitt, Chairman and Chief Executive officer.
Revenues for fiscal 2010 were $47.2 million, up 21 percent from $39.0 million in the prior year. The increase in revenues is primarily related to obtaining business at new customer facilities, increases from existing customers and expansion into new product lines such as those associated the First Biomedical acquisition.
Gross profit for fiscal 2010 was $33.5 million, up 17 percent from $28.6 million in the prior year. It represented 71 percent of revenues for the latest year, compared with 73 percent in fiscal 2009. The decrease in the gross margin percentage was primarily related to higher pump depreciation and a higher mix of pump sales and services, as compared to third party billings.
Selling, general and administrative expenses (SG&A) were $34.5 million, 48 percent higher than fiscal 2009’s $23.3 million. As a percent of revenues, SGA was 73 percent for the latest year, compared to 60% in fiscal 2009. The increases were primarily related to an increase in stock based compensation, along with the pre/post acquisition expenses of acquired business. Excluding the one-time expenses, on a normalized basis SGA, as a percent of revenues, is approximately the same as the 60% in fiscal 2009.
Adjusted EBITDA was $14.0 million for the latest fiscal year, up 8 percent from $12.9 million a year ago. The company utilizes Adjusted EBITDA as a means to measure its operating performance. A reconciliation from Adjusted EBITDA, a non-GAAP measure, to net income can be found in the appendix.
Other loss for the latest year was $2.3 million versus $3.6 million other loss a year ago, reflecting reduced interest expense, gain on derivatives, and extinguishment of long-term debt. As a result, the fiscal 2010 net loss was $1.9 million, equal to $0.09 loss per diluted share, versus a $0.8 million net income, equal to $0.04 income per diluted share, a year earlier.
Fourth Quarter Growth in Revenues and Adjusted EBITDA
Revenues for the latest quarter were $13.1 million, up 23 percent from $10.7 million for the prior-year period. Gross profit increased to $9.0 million or 16% from $7.8 million in the fiscal 2009 fourth quarter. SG&A increased to $12.0 million from $6.4 million. Other expense of $0.4 million compared with $0.3 million of other income a year ago. The net loss for the most recent quarter was $2.2 million, equal to $0.11 per diluted share, versus the prior year quarter’s net income of $1.0 million, equal to $0.05 per diluted share. Adjusted EBITDA for the latest quarter was $3.7 million, up 15 percent from $3.2 million for the prior-year period.
Financial Condition
Net cash provided by operations for fiscal 2010 was $10.8 million, up 11 percent from $9.7 million for the prior year. The latest year’s results reflected higher levels of stock based compensation, depreciation and amortization of goodwill, accounts payable, inventory and amounts accrued. The company reduced capital expenditures from $4.6 million in fiscal 2009 to $2.4 million and paid $16.6 million in cash for acquisition of First Biomedical in June 2010. The cash balance decreased by $2.7 million and the company ended the year with a cash balance of $5.0 million with $26.6 million in long-term debt, net of current.
Conference Call
InfuSystem Holdings, Inc. will host a conference call to share the results of its fourth quarter and full-year fiscal 2010 results on Thursday, March 10, at 10:00 a.m. Eastern Time. Chairman and Chief Executive Officer Sean McDevitt and Jim Froisland, Chief Financial Officer, will discuss the company’s financial performance and answer questions from the financial community.
The company invites interested investors to listen to the presentation, which will be carried live on the company’s Web site: www.infusystem.com in the Investors section. To participate by telephone, the dial-in number is 800-446-1671 with confirmation number 29138075. Those who wish to listen should either dial in or go to the Web site several minutes prior to the call to register. A replay of the call can be accessed by dialing 888-843-7419, pass-code 29138075#. An online archive of the conference call will remain on the company’s Web site for the following 30 days.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading national provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The company’s stock is traded on the NYSE Amex under the symbol INFU.
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially form those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks, detailed from time to time in the company’s publicly filed documents.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
FINANCIAL TABLES FOLLOW
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES | ||
CONSOLIDATED BALANCE SHEETS | ||
(in thousands, except share data) | December 31,
2010 |
December 31,
2009 |
ASSETS | ||
Current Assets: | ||
Cash and cash equivalents | $ 5,014 | $ 7,750 |
Accounts receivable, less allowance for doubtful accounts of $1,796 and $1,842 at December 31, 2010 and 2009, respectively | 6,679 | 5,517 |
Inventory | 1,699 | 925 |
Prepaid expenses and other current assets | 750 | 395 |
Deferred income taxes | 1,147 | 125 |
Total Current Assets | 15,289 | 14,712 |
Property & equipment, net | 16,672 | 13,499 |
Deferred debt issuance costs, net | 658 | 781 |
Goodwill | 64,092 | 56,580 |
Intangible assets, net | 33,252 | 28,911 |
Other assets | 401 | 207 |
Total Assets | $ 130,364 | $ 114,690 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current Liabilities: | ||
Accounts payable | $ 2,016 | $ 1,306 |
Other current liabilities | 4,631 | 1,573 |
Derivative liabilities | 183 | 2,670 |
Current portion of long-term debt | 5,551 | 5,501 |
Total Current Liabilities | 12,381 | 11,050 |
Long-term debt, net of current portion | 26,646 | 18,640 |
Deferred income taxes | 5,788 | 3,314 |
Other liabilities | 406 | 221 |
Total Liabilities | $ 45,221 | $ 33,225 |
Stockholders’ Equity | ||
Preferred stock, $.0001 par value: authorized 1,000,000 shares; none issued | — | — |
Common stock, $.0001 par value; authorized 200,000,000 shares; issued 21,163,337 and 18,734,144, respectively; outstanding 21,117,516 and 18,734,144, respectively | 2 | 2 |
Additional paid-in capital | 87,004 | 81,410 |
Accumulated other comprehensive loss | (64) | — |
Retained (deficit) earnings | (1,799) | 53 |
Total Stockholders’ Equity | 85,143 | 81,465 |
Total Liabilities and Stockholders’ Equity | $ 130,364 | $ 114,690 |
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES | ||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||
Three Months Ended December 31, | Year Ended December 31, | |||
(in thousands, except per share data) | 2010 | 2009 | 2010 | 2009 |
Net revenues | 13,075 | 10,662 | 47,229 | 38,964 |
Cost of revenues: | ||||
Product and supply costs | 2,206 | 1,753 | 7,730 | 6,200 |
Pump depreciation and disposals | 1,860 | 1,121 | 5,945 | 4,127 |
Gross profit | 9,009 | 7,788 | 33,545 | 28,637 |
Sales, general and administrative expenses: | ||||
Provision for doubtful accounts | 1,061 | 1,272 | 4,515 | 4,006 |
Amortization of intangibles | 644 | 457 | 2,259 | 1,827 |
Selling and marketing | 2,348 | 1,509 | 7,087 | 5,258 |
General administrative | 7,960 | 3,190 | 20,622 | 12,218 |
Total sales, general and administrative expenses | 12,013 | 6,428 | 34,483 | 23,309 |
Operating (loss) income | (3,004) | 1,360 | (938) | 5,328 |
Other (loss) income: | ||||
Gain (loss) on derivatives and other income | 417 | 1,122 | 207 | (78) |
Interest expense | (571) | (831) | (3,352) | (3,499) |
Gain on extinguishment of long-term debt | — | — | 1,118 | — |
Other expense | (258) | — | (258) | — |
Total other (loss) income | (412) | 291 | (2,285) | (3,577) |
(Loss) income before income taxes | (3,416) | 1,651 | (3,223) | 1,751 |
Income tax benefit (expense) | 1,258 | (685) | 1,371 | (977) |
Net (loss) income | (2,158) | 966 | (1,852) | 774 |
Net (loss) income per share: | ||||
Basic | (0.11) | 0.05 | (0.09) | 0.04 |
Diluted | (0.11) | 0.05 | (0.09) | 0.04 |
Weighted average shares outstanding: | ||||
Basic | 20,261,591 | 18,697,729 | 19,721,378 | 18,609,797 |
Diluted | 20,261,591 | 18,956,690 | 19,721,378 | 18,931,356 |
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
(in thousands) | Year Ended
December 31, 2010 |
Year Ended
December 31, 2009 |
Year Ended
December 31, 2008 |
OPERATING ACTIVITIES | |||
Net (loss) Income | $ (1,852) | $ 774 | $ 9,959 |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||
(Gain) loss on derivative liabilities | (207) | 78 | (9,815) |
(Gain) on extinguishment of long-term debt | (1,118) | — | — |
Provision for doubtful accounts | 4,515 | 4,006 | 3,187 |
Depreciation | 5,357 | 4,122 | 3,935 |
Loss on disposal of pumps | 994 | 342 | 553 |
Amortization of intangible assets | 2,259 | 1,827 | 1,827 |
Amortization of deferred debt issuance costs | 980 | 495 | 642 |
Stock-based compensation | 3,860 | 753 | 1,550 |
Deferred income taxes | (1,236) | 2,254 | 935 |
Changes in assets and liabilities, exclusive of effects of acquisitions: | |||
(Increase) in accounts receivable, net of provision | (3,948) | (5,355) | (1,835) |
(Increase) decrease in other current assets | (506) | (253) | 560 |
(Increase) in other assets | (173) | (207) | — |
Increase (decrease) in accounts payable and other liabilities | 2,252 | 872 | (601) |
(Decrease) in derivative liabilities from termination of interest rate swap | (365) | — | — |
NET CASH PROVIDED BY OPERATING ACTIVITIES | 10,812 | 9,708 | 10,897 |
INVESTING ACTIVITIES | |||
Capital expenditures | (2,444) | (4,612) | (1,733) |
Cash paid for acquisition, net of cash acquired | (16,616) | — | — |
Proceeds from sale of property | — | 1 | 10 |
Payment of deferred acquisition costs | — | — | (105) |
Cash received for acquisition from I-Flow | — | — | 784 |
NET CASH USED IN INVESTING ACTIVITIES | (19,060) | (4,611) | (1,044) |
FINANCING ACTIVITIES | |||
Principal payments on term loan | (22,623) | (8,565) | (2,044) |
Cash proceeds from term loan | 30,000 | — | — |
Capitalized debt issuance costs | (808) | — | — |
Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation | (167) | (135) | (195) |
Treasury shares repurchased | (68) | — | — |
Principal payments on capital lease obligations | (822) | (160) | (61) |
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 5,512 | (8,860) | (2,300) |
Net change in cash and cash equivalents | (2,736) | (3,763) | 7,553 |
Cash and cash equivalents, beginning of period | 7,750 | 11,513 | 3,960 |
Cash and cash equivalents, end of period | $ 5,014 | $ 7,750 | $ 11,513 |
INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES | ||||
GAAP RECONCILIATION | ||||
Reconciliation from Net Income to Adjusted EBITDA: | ||||
Three Months Ended | Year Ended | |||
December 31, | December 31, | |||
2010 | 2009 | 2010 | 2009 | |
Net (loss) income | $ (2,158) | $ 966 | $ (1,852) | $ 774 |
Adjustments: | ||||
Interest expense | 571 | 831 | 3,352 | 3,499 |
Income tax (benefit) expense | (1,259) | 685 | (1,371) | 977 |
Depreciation — Pumps | 1,376 | 1,058 | 4,960 | 3,785 |
Depreciation — Other | 112 | 93 | 397 | 337 |
Amortization | 644 | 457 | 2,259 | 1,827 |
EBITDA | $ (714) | $ 4,090 | $ 7,745 | $ 11,199 |
Adjustments: | ||||
(Gain) loss on derivatives and other income | (417) | (1,122) | (207) | 78 |
Other expense | 258 | — | 258 | — |
Stock based compensation | 4,098 | 224 | 5,909 | 753 |
Acquisition costs | — | — | 965 | — |
Termination Benefits | 450 | — | 450 | 877 |
(Gain) on loan payoff discount | — | — | (1,118) | — |
Adj. EBITDA | $ 3,675 | $ 3,192 | $ 14,002 | $ 12,907 |
CONTACT: INVESTOR CONTACT: Pat LaVecchia Vice Chairman Info@InfuSystem.com 800-962-9656
TraderPower Featured Companies
Top Small Cap Market News
- $SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Closes on $8.2M Private Placement
- $CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences
- $ATBHF Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Releases Updated Report on Storm Copper Project Drilling Program
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
- $LEXX InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Subject Dosing in Human Pilot Study #3 Evaluating Oral DehydraTECH-Processed Tirzepatide
- $FSTTF InvestorNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Shares Additional Information on the PyroDelta Thermoelectric Generator, Relationship with Subsidiary
- $TMET.V Gold Stutters as Strong US Jobs Data Dampens Expectations of Large Rate Cuts
- $RFLXF JPMorgan Executive Says US Backlash Against ESG Is Exaggerated
- $SFWJ InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses
- $EAWD IEA Hosts G20 Ministers, Influential Personalities to Discuss Clean and Affordable Energy Transition
Recent Posts
- $EAWD IEA Hosts G20 Ministers, Influential Personalities to Discuss Clean and Affordable Energy Transition
- $SFWJ InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses
- $RFLXF JPMorgan Executive Says US Backlash Against ESG Is Exaggerated
- $TMET.V Gold Stutters as Strong US Jobs Data Dampens Expectations of Large Rate Cuts
- $FSTTF InvestorNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Shares Additional Information on the PyroDelta Thermoelectric Generator, Relationship with Subsidiary
- $LEXX InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Subject Dosing in Human Pilot Study #3 Evaluating Oral DehydraTECH-Processed Tirzepatide
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
- $ATBHF Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Releases Updated Report on Storm Copper Project Drilling Program
Recent Comments
Archives
- October 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009